by sanhitamehta | Apr 4, 2024 | News&blogs
In the UK, experts say that 1 in 6 people dying of lying cancer are non-smokers. Lung Cancer is notoriously known as a ‘Smoker’s Disease’. However, it is becoming increasingly common amongst non-smokers, especially women. Why is this? Car fumes,...
by sanhitamehta | Mar 21, 2024 | Uncategorized
We are happy to share that we have been recognised by Cancer Research Horizons during the 2024 Innovation & Entrepreneurship Awards! This award focused on celebrating the UK’s most innovative and enterprising efforts in Oncology Research. Averywell was...
by sanhitamehta | Sep 20, 2023 | News&blogs, Uncategorized
We are happy to share that Averywell was listed as a finalist at the 2023 BioCap Conference held by Bionow. Bionow is a non-profit hoping to support the biomedical, pharma and life sciences sectors across North England. They aim to provide the tools and support for...
by sanhitamehta | Jul 21, 2023 | News&blogs, Uncategorized
Manchester MedTech company Averywell is set to start UK clinical trials on a ground breaking early detection test for lung cancer later this year. Averywell has developed a proprietary technology to detect microRNA biomarkers at the early onset of lung cancer –...